178 related articles for article (PubMed ID: 11858100)
1. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in patients with ischaemic heart disease or myocardial infarction.
Bossowska A; Kiersnowska-Rogowska B; Bossowski A; Galar B; Sowiński P
Kardiol Pol; 2003 Aug; 59(8):105-14. PubMed ID: 14560325
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease.
Jafarzadeh A; Esmaeeli-Nadimi A; Nough H; Nemati M; Rezayati MT
Anadolu Kardiyol Derg; 2009 Apr; 9(2):75-83. PubMed ID: 19357047
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
6. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
Tang L; Luo Q; Zhou X; Xia R
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa.
Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Soppi E
Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):337-54. PubMed ID: 8872489
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the relationship between the level of cytokine and liver function in patients with clonorchiasis sinensis].
Cai LS; Xiao JY; Xin H; Zhu LX; Chen G; Zhang T; Wang GZ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Feb; 22(1):54-6. PubMed ID: 15283270
[TBL] [Abstract][Full Text] [Related]
9. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
11. Pentoxyfilline treatment does not influence the plasma levels of IL-2 and sIL-2R in limited scleroderma patients.
Chibowska M; Krasowska D; Weglarz J
Med Sci Monit; 2001; 7(2):282-8. PubMed ID: 11257736
[TBL] [Abstract][Full Text] [Related]
12. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
Wang Z; Li D; Yang J
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of five cytokines in the serum of malignant lymphoma patients].
Zhu H; Wang Y; Han X
Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):85-8. PubMed ID: 10921109
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
15. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
[TBL] [Abstract][Full Text] [Related]
16. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Yoshida A; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Matsushima K; Sasayama S
J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055
[TBL] [Abstract][Full Text] [Related]
18. [Dynamic monitoring of sIL-2R, IL-2 and IL-6 levels of serum after double-hand transplantation].
Xiang D; Pei G; Qiu Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 May; 18(3):232-5. PubMed ID: 15211844
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between the serum levels of interleukin-2 and soluble interleukin-2 receptor and the response to immunosuppressive therapy in severe aplastic anemia patients].
Shao Z; Chen K; Chen G; Zhang Y; Wang T; Zou R; Zhou X; Zhou Y; Chu Y
Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):180-2. PubMed ID: 15622762
[TBL] [Abstract][Full Text] [Related]
20. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
